leisure time -WSS

leisure time

author：hotspot 2025-09-03 07:53:35 - browse：772

This image provided by Amylyx Pharmaceuticals shows the drug Relyvrio. The maker of a much-debated drug for Lou Gehrig’s disease said Friday, March 8, 2024 its therapy failed to help patients in a large follow-up study, but stopped short of committing to follow through on a prior pledge to pull the drug from the U.S. market. — Relyvrio, an ALS drug made by Amylyx Pharmaceuticals, failed to beat placebo in a key clinical trial. Amylyx Pharmaceuticals via AP

The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with an approved medicine that doesn’t appear to work.

Amylyx Pharmaceuticals’ announcement Friday that its drug, marketed as Relyvrio, failed to beat placebo in a pivotal study marks “a sad day for us, but we have to believe the data,” said Mary Catherine Collet, an ALS advocate. “These are hard scientific facts that we have to face, and I appreciate that they’re not trying to spin us like some cheerleading practice.”

The question now is whether Relyvrio, approved in 2022, should be removed from the market entirely — and whether the Food and Drug Administration made a mistake by authorizing it in the first place. After years of pressure from patient advocates, the agency has taken a more flexible approach to medicines for devastating, incurable diseases like ALS. But the case of Relyvrio, which made $381 million in sales and $49 million in profit for Amylyx last year, has underlined questions about the limits of regulatory leniency.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： The UK government moves asylum

WSS

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Baby aspirin cuts fat buildup in liver disease patients, in small study

Neuroscience’s long legacy of racism

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

entertainment

leisure time

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

Creating egg and sperm cells from stem cells raises ethical issues

Tori Bowie and the unacceptable rates of Black maternal death

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

In Memoriam: Notable people who died in 2023

Physicians and social media: If you see something, say something?

Bright Health sells Medicare Advantage business to Molina

NYC plans to house migrants on an island in the East River

hotspot

Virtual Event: March of the Biosimilars

Neuroscience’s long legacy of racism

Positive childhood experiences can help future health

CVS Caremark has created a new ploy: the drug ‘rebate credit’

At least 12 people were injured in a blast at a port in northwest Turkey

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

leisure time

hotspot

explore

Wikipedia